Signature TMA 07-18-2025 Newbiz

IMCAS World Congress 2026

IMCAS World Congress entrusts its media image to Thomas Marko & Associés

Following a consultation process, COMEXPOSIUM HEALTHCARE, a subsidiary of the COMEXPOSIUM group and a major player in medical and scientific events, has renewed its confidence in Thomas Marko & Associés to orchestrate media relations for the IMCAS 2026 World Congress, both in France and internationally. For the third year running, the agency, which specializes in the health, care and beauty sectors, will be helping to raise the profile of this world-class event dedicated to dermatology, plastic surgery and aesthetic medicine, to be held from January 29 to 31, 2026 at the Palais des Congrès in Paris.

Scientific and medical event, world and French leader

Launched in 1998, the IMCAS World Congress is now the world's largest congress in its specialties, and the largest international medical congress organized in France for all disciplines. It has become the annual meeting point for the world's leading experts in dermatology, plastic surgery and aesthetic medicine, offering an immersion in the latest discoveries, from revolutionary plastic surgery techniques to innovative dermatological treatments. In 2025, the congress attracted over 20,000 participants from 136 countries, with 1,000 speakers, 370 exhibitors and 317 hours of scientific training.

Thanks to its in-depth understanding of the specific challenges facing the medical and paramedical sectors, Thomas Marko & Associés designs high value-added communication and influence strategies for healthcare institutions, laboratories, professional organizations and brands. With the IMCAS World Congress, the agency is supporting the key event for the latest scientific advances and cutting-edge innovations in medical aesthetics, to support its media coverage and boost its visibility with target audiences.

The themes of the 2026 edition will include cutting-edge technologies, solutions based on regenerative medicine and applications of artificial intelligence that are shaping the medicine of tomorrow. Thanks to a dynamic program combining live demonstrations, expert roundtables and hands-on workshops, attendees will benefit from privileged access to the most advanced protocols and next-generation treatments.

The event enables both established specialists and emerging young talents to enrich their knowledge, hone their skills and explore the trends that are redefining industry standards.

IMCAS is also extending its reach with annual editions in America, Asia and China. It is reinforcing its leadership in continuing education with the IMCAS Academy, which offers over 10,000 educational contents to 33,000 physician members.

Back to news list